A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

NCT05583838 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Previously Treated Primary Immune Thrombocytopenia

Interventions

DRUG: rhTPO
DRUG: Eltrombopag

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]